iShares MSCI United Kingdom (FTSE) vs State Street SPDR S&P Biotech ETF — how do they compare? iShares MSCI United Kingdom (FTSE) trades at $46.95, while State Street SPDR S&P Biotech ETF trades at $151.9. Which is the better fit depends on your goals.
| EWU | XBI | |
|---|---|---|
Sector | Broad Market / Factor | Broad Market / Factor |
52-Week High | $48.68 | $164.28 |
52-Week Low | $39.80 | $85.16 |
Signals from Pluang's Aura AI — not financial advice
EWU trades at $46.79, up 1.04% with a bullish technical signal from moving averages. The stock shows neutral oscillator readings with RSI at 62.29. Recent news highlights Middle East tensions impacting European markets, though energy sector gains provide some offset. Key support sits at $46 with resistance at $47.
The outlook remains cautiously optimistic given technical strength, though fundamental data is limited. Risks include geopolitical volatility and broader market sentiment. Investment opportunity hinges on UK economic recovery and energy sector performance amid current market conditions.
XBI trades at $155.19, down 0.23% on the day, with a bullish technical signal from moving averages. Recent news highlights strong biotech sector momentum, with the ETF gaining nearly 17% in a month (24/7 Wall Street, 2026-07-06). Analyst consensus is neutral with a single hold rating, while technical indicators show a neutral RSI and mixed ADX signals. Support is seen near $153, with resistance at $157.
The outlook for XBI is supported by sector strength and M&A activity, but high volatility and a neutral analyst stance suggest cautious optimism. Key risks include regulatory uncertainty and macroeconomic pressures, requiring careful risk management for investors.
Trailing returns across standard periods
Latest headlines on both assets
EWU is a country-specific ETF that tracks the performance of the United Kingdom equity market. It provides exposure to large and mid-sized UK companies, with significant weightings in financials, energy, and healthcare, including Shell, AstraZeneca, and HSBC.
Read more on EWU →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →